-+ 0.00%
-+ 0.00%
-+ 0.00%

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga·05/06/2026 12:06:21
Listen to the news

Gainers

  • Avalo Therapeutics (NASDAQ:AVTX) stock moved upwards by 50.9% to $24.53 during Wednesday's pre-market session. The company's market cap stands at $370.5 million.
  • GlucoTrack (NASDAQ:GCTK) stock moved upwards by 45.2% to $1.06. The market value of their outstanding shares is at $2.6 million.
  • Simulations Plus (NASDAQ:SLP) shares increased by 35.66% to $21.31. The market value of their outstanding shares is at $317.4 million.
  • MannKind (NASDAQ:MNKD) stock moved upwards by 20.27% to $3.44. The market value of their outstanding shares is at $869.0 million. As per the news, the Q1 earnings report came out today.
  • Cypherpunk Technologies (NASDAQ:CYPH) shares increased by 19.65% to $1.28. The company's market cap stands at $104.5 million.
  • Atlantic International (NASDAQ:ATLN) shares rose 17.32% to $1.49. The company's market cap stands at $100.7 million.

Losers

  • PAVmed (NASDAQ:PAVM) shares decreased by 27.9% to $5.8 during Wednesday's pre-market session. The company's market cap stands at $58.5 million.
  • Apimeds Pharmaceuticals (AMEX:APUS) stock declined by 27.67% to $2.17. The market value of their outstanding shares is at $37.7 million. As per the press release, Q4 earnings came out 2 days ago.
  • TransMedics Group (NASDAQ:TMDX) stock declined by 22.04% to $74.01. The market value of their outstanding shares is at $3.2 billion. As per the press release, Q1 earnings came out yesterday.
  • Akanda (NASDAQ:AKAN) shares fell 19.22% to $24.24. The company's market cap stands at $16.0 million.
  • Hyperion DeFi (NASDAQ:HYPD) stock decreased by 18.63% to $3.8. The market value of their outstanding shares is at $38.1 million.
  • Alphatec Holdings (NASDAQ:ATEC) shares fell 17.01% to $8.49. The market value of their outstanding shares is at $1.5 billion. The company's, Q1 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.